Symbol="ZLAB"
AssetType="Common Stock"
Name="Zai Lab Ltd"
Description="Zai Lab Limited, a biopharmaceutical company, discovers, licenses, develops and markets therapies to treat cancer, autoimmune and infectious diseases in China. The company is headquartered in Shanghai, China."
CIK="1704292"
Exchange="NASDAQ"
Currency="USD"
Country="China"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="4560 JINKE ROAD, BLDG. 1, 4F, PUDONG, SHANGHAI, CHINA"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="2668941000"
EBITDA="-385244000"
PERatio="None"
PEGRatio="None"
BookValue="10.39"
DividendPerShare="0"
DividendYield="0"
EPS="-4.32"
RevenuePerShareTTM="2.409"
ProfitMargin="-1.774"
OperatingMarginTTM="-1.705"
ReturnOnAssetsTTM="-0.184"
ReturnOnEquityTTM="-0.355"
RevenueTTM="231113000"
GrossProfitTTM="-145386000"
DilutedEPSTTM="-4.32"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0.344"
AnalystTargetPrice="77.73"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="17.13"
PriceToBookRatio="3.106"
EVToRevenue="12.53"
EVToEBITDA="-4.723"
Beta="1.087"
num_52WeekHigh="53.95"
num_52WeekLow="20.98"
num_50DayMovingAverage="28.99"
num_200DayMovingAverage="33.67"
SharesOutstanding="98389000"
DividendDate="None"
ExDividendDate="None"
symbol="ZLAB"
open="25.21"
high="25.63"
low="23.77"
price="24.19"
volume="845856.00"
latest_trading_day="2023-08-08"
previous_close="26.46"
change="-2.27"
change_percent="-8.5790%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="91"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="9"
Volume_recent_avg="577496"
Change_recent_avg="-0.17"
Delta_recent_avg="1.64"
Variance_recent_avg="0.82"
Change_ratio_recent_avg="-0.63"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="9"
Aroon_momentum_negative="91"
image_negative_thumbnail_id_1="95"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0081.jpeg"
image_negative_thumbnail_id_2="1101"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0134.jpeg"
image_neutral_thumbnail_id_1="560"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0039.jpeg"
image_neutral_thumbnail_id_2="567"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0032.jpeg"
image_positive_thumbnail_id_1="647"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0061.jpeg"
image_positive_thumbnail_id_2="657"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0051.jpeg"
image_professor_thumbnail_id_1="1187"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0021.jpeg"
image_professor_thumbnail_id_2="1180"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0014.jpeg"
